|
Repligen Has Returned 21.0% Since SmarTrend Recommendation (RGEN)
Dec 04, 2012 (SmarTrend(R) Spotlight via COMTEX) --
SmarTrend identified an Uptrend for Repligen (NASDAQ:RGEN) on August 20th, 2012 at $5.07. In approximately 4 months, Repligen has returned 21.03% as of today's recent price of $6.13.
In the past 52 weeks, shares of Repligen have traded between a low of $2.90 and a high of $7.29 and are now at $6.13, which is 111% above that low price. Over the past week, the 200-day moving average (MA) has gone up 0.6% while the 50-day MA has advanced 0.4%.
Repligen Corporation is a biotechnology company. The Company develops therapeutics for the treatment of diseases of the central nervous system. Repligen owns owns intellectual property on monoclonal antibody and antibody fusion products.
SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Repligen shares.Log in and add Repligen (RGEN) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.
Write to Chip Brian at cbrian@mysmartrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup
[ Back To Technology News's Homepage ]
|
Internet Telephony Magazine
Click here to read latest issue
CUSTOMER 
Cloud Computing Magazine
Click here to read latest issue
M2M Evolution Magazine
Call Center/CRM
Info Tech 
IP Communications 
Mobile 
Green 
Satellite 
Robotics 
